Hemoccult II SENSA by Beckman Coulter
It is not a test for colorectal cancer or any other specific disease. Hemoccult II SENSA is the enhanced Hemoccult product that provides improved readability and higher clinical sensitivity over regular Hemoccult and other FOBTs. Hemoccult II SENSA has been proven to give the highest clinical sensitivity readings (92%) (1,2) and offers the ability to find more true positives of occult blood. Polyps and cancer may bleed intermittently. Hemoccult II SENSA triple slide products are designed so patients can collect serial specimens over three days. This increases the probability of detecting hidden blood from polyps and cancer.
Hemoccult SENSA Features:
- Improved readability, intense blue reaction
- Higher clinical sensitivity
- Detection of more true positives
- 14-day on-slide stability
- Used in colorectal cancer screening programs worldwide
- Comprehensive patient educational support
- CLIA Category
- CLIA-waived
Hemoccult II SENSA Slides are designed so patients can collect serial specimens at home from bowel movements over 3 days. After the patient prepares the Hemoccult II SENSA test, it may be returned in person or by mail (using the Hemoccult Mailing Pouch) to the laboratory, hospital or medical office for developing and interpretation.
Hemoccult SENSA Single Slides are convenient for use when single fecal specimens are collected for routine in-office gastrointestinal screening.
References:
1. Data on file, Product Development department, Beckman Coulter, Inc., Rapid Diagnostics (formerly SmithKline Diagnostics).
2. Baker, J., et al.: ""Readability and sensitivity of two guaiac-based fecal occult blood tests,"" Gastroenterol. 94(5):A5, 1988.
Product Overview
